We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+9.42%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$158B
AUM Growth
-$60B
Cap. Flow
-$70.1B
Cap. Flow %
-44.4%
Top 10 Hldgs %
24.44%
Holding
5,371
New
314
Increased
1,955
Reduced
1,669
Closed
872

Sector Composition

Rank Sector Weight
1 Technology 28.28%
2 Healthcare 11.27%
3 Financials 10.52%
4 Consumer Discretionary 10.12%
5 Communication Services 7.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AKYA
3901
DELISTED
Akoya BioSciences
AKYA
$26.7K ﹤0.01%
3,615
-4,364
-55% -$29.1K
BCAB icon
3902
BioAtla
BCAB
$5.46M
$26.5K ﹤0.01%
+177
New +$30.4K
PLX icon
3903
Protalix BioTherapeutics
PLX
$191M
$26.5K ﹤0.01%
13,230
+11,230
+562% +$26.8K
TVRD
3904
Tvardi Therapeutics
TVRD
$19.7M
$26.4K ﹤0.01%
260
-530
-67% -$73K
LVWR icon
3905
LiveWire
LVWR
$371M
$26.4K ﹤0.01%
+2,236
New +$18.6K
SMLR
3906
DELISTED
Semler Scientific
SMLR
$26.2K ﹤0.01%
999
-10,064
-91% -$265K
FSFG
3907
DELISTED
First Savings Financial Group
FSFG
$26K ﹤0.01%
1,964
NXU
3908
DELISTED
Nxu, Inc. Class A Common Stock
NXU
$25.9K ﹤0.01%
+16
New +$25.7K
MBIO icon
3909
Mustang Bio
MBIO
$4.32M
$25.7K ﹤0.01%
+83
New +$20.8K
FEAM icon
3910
5E Advanced Materials
FEAM
$45.7M
$25.7K ﹤0.01%
340
-523
-61% -$49.7K
RBOT
3911
DELISTED
Vicarious Surgical
RBOT
$25.6K ﹤0.01%
467
-469
-50% -$29.9K
YSG
3912
Yatsen Holding
YSG
$322M
$25.3K ﹤0.01%
5,000
BIRD icon
3913
Smartbird Inc
BIRD
$19.5M
$25.2K ﹤0.01%
1,000
-1,441
-59% -$36K
PPLT
3914
abrdn Physical Platinum Shares ETF
PPLT
$1.88B
$25.1K ﹤0.01%
3,000
SBDS
3915
DELISTED
Solo Brands Inc
SBDS
$24.8K ﹤0.01%
109
-171
-61% -$42.5K
DOO
3916
Bombardier Recreational Products
DOO
$4.54B
$24.7K ﹤0.01%
292
-1,253
-81% -$95.1K
KLXE icon
3917
KLX Energy Services
KLXE
$45M
$24.6K ﹤0.01%
2,532
-2,512
-50% -$24.7K
CGNT icon
3918
Cognyte Software
CGNT
$659M
$24.5K ﹤0.01%
4,030
+4,000
+13,333% +$18.6K
SBT
3919
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
$24.3K ﹤0.01%
4,441
-4,405
-50% -$23.1K
VRCA icon
3920
Verrica Pharmaceuticals
VRCA
$89.7M
$24.1K ﹤0.01%
417
-1,275
-75% -$77.4K
HARP
3921
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$24K ﹤0.01%
3,379
+2,703
+400% +$18.7K
RSVR
3922
DELISTED
Reservoir Media
RSVR
$23.8K ﹤0.01%
3,957
-6,487
-62% -$41K
CRBN icon
3923
iShares Low Carbon Optimized MSCI ACWI ETF
CRBN
$1.15B
$23.8K ﹤0.01%
152
AIRS icon
3924
AirSculpt Technologies
AIRS
$339M
$23.7K ﹤0.01%
2,751
-3,473
-56% -$22.7K
CIFR icon
3925
Cipher Digital
CIFR
$9.13B
$23.6K ﹤0.01%
8,262
-16,509
-67% -$40.7K

Similar funds

Barclays's Q2 2023 Portfolio in Review

As of Q2 2023, Barclays held 5,371 positions worth $158B, down 28% from $218B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Barclays withdrew a net $70.1B in Q2 2023, closing 872 positions and reducing 1,669 holdings. Its most notable exit was DCP Midstream, LP, an estimated $47.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Barclays opened a new position in State Street SPDR Nuveen ICE Municipal Bond ETF worth $36.9M.

  • Barclays's largest Q2 2023 buy was State Street SPDR Nuveen ICE Municipal Bond ETF: 799,988 shares worth $36.9M.
  • Barclays added most to Apple in Q2 2023, an estimated $2.78B increase.
  • Barclays's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.45B.
  • Barclays fully exited DCP Midstream, LP in Q2 2023, selling an estimated $47.3M.
  • Barclays's ten largest holdings make up 24% of its $158B portfolio in Q2 2023.
  • Barclays opened 314 new positions and closed 872 in Q2 2023.
  • Barclays's portfolio value fell 28% quarter-over-quarter to $158B.

Based on Barclays's 13F filing for Q2 2023, filed 3 Aug 2023.